A nurse is caring for a 58-year-old patient with ovarian cancer receiving cisplatin as part of combination chemotherapy. The patient's baseline creatinine is 0.9 mg/dL and BUN is 18 mg/dL, and this is the third cycle of treatment. Which nursing intervention is the MOST important to prevent nephrotoxicity?

Adequate hydration with normal saline before and after cisplatin infusion is critical to prevent nephrotoxicity by diluting drug concentration and maintaining urine output. Other interventions like CBC monitoring, antiemetics, or vital signs checks do not directly prevent kidney damage.

Core Nursing Explanation Key Concept Analysis: This question tests the critical nursing intervention to prevent a major dose-limiting side effect of a key chemotherapy drug. The core theme is Cisplatin-induced nephrotoxicity. Cisplatin is a platinum-based alkylating agent highly effective against various solid tumors, including ovarian cancer. However, it is excreted by the kidneys and can cause direct tubular damage, leading to acute kidney injury (AKI). The pathophysiology involves cisplatin accumulation in renal tubular cells, causing oxidative stress, inflammation, and cell death. Preventing this toxicity is paramount to allow for continued, effective treatment.

Answer Rationale: Key Point! The most important intervention is Ensuring adequate hydration with normal saline before and after infusion. This is the standard of care. The mechanism is two-fold: 1) Volume expansion increases renal blood flow and glomerular filtration rate (GFR), reducing the concentration of cisplatin in the renal tubules. 2) The chloride ions in normal saline compete with cisplatin for uptake into tubular cells, further limiting its nephrotoxic effects. This proactive intervention is directly aimed at preserving renal function, as evidenced by the patient's normal baseline creatinine (0.9 mg/dL) and BUN (18 mg/dL), which we must protect.

Distractor Analysis: Watch out for confusion! Option 1 (Monitor CBC every 8 hours): This addresses myelosuppression (bone marrow suppression), another common side effect of cisplatin, but it is a monitoring action, not a preventive one for nephrotoxicity. It does not stop kidney damage from occurring.
Option 3 (Administer antiemetics 30 minutes before chemotherapy): This is crucial for managing the severe nausea and vomiting associated with cisplatin (highly emetogenic), but it prevents gastrointestinal distress, not renal toxicity. Both hydration and antiemetics are important, but the question specifically asks for the most important to prevent nephrotoxicity.
Option 4 (Check vital signs every 15 minutes during infusion): While monitoring for infusion reactions (e.g., anaphylaxis) and fluid overload is part of standard care, this frequency is excessive for a routine infusion and is not the primary strategy for kidney protection. It is a general safety measure.

Related Concepts: Other key toxicities of cisplatin include ototoxicity (hearing loss, tinnitus), peripheral neuropathy, and severe electrolyte imbalances like hypomagnesemia and hypokalemia due to renal wasting. The nursing process involves pre-hydration, monitoring intake/output (I&O), and checking serum creatinine, BUN, and electrolytes before each cycle.

Concept Summary

Concept	Key Points
Cisplatin Nephrotoxicity	Dose-limiting. Caused by tubular damage. Prevention is key via aggressive hydration.
Hydration Protocol	IV normal saline before, during, and after cisplatin infusion. Goal: maintain urine output >100 mL/hr.
Other Cisplatin Toxicities	Myelosuppression (monitor CBC), Severe N/V (give antiemetics), Ototoxicity, Neuropathy, Electrolyte loss.
Nursing Assessment	Baseline & serial renal function (Cr, BUN), I&O, electrolytes (Mg, K), hearing assessment.

Side-by-Side Comparison!

Chemotherapy Agent	Key Dose-Limiting Toxicity	Primary Preventive Nursing Intervention
Cisplatin	Nephrotoxicity	Aggressive IV hydration with NS
Doxorubicin	Cardiotoxicity (cumulative)	Monitor ejection fraction (EF) via MUGA scan/ECHO
Bleomycin	Pulmonary fibrosis	Monitor pulmonary function tests (PFTs), O2 saturation
Vincristine	Peripheral Neuropathy	Assess for numbness, tingling, foot drop, constipation

Anatomy, Physiology & Pharmacology Points

• Renal Physiology: The proximal tubule is the primary site of cisplatin accumulation and injury. Good hydration maintains high tubular flow rate, flushing the toxin.
• Pharmacology: Cisplatin is an alkylating agent that cross-links DNA, inhibiting cell division. It is not phase-specific (works on cells in any phase of the cell cycle).
• Lab Values: Normal Serum Creatinine: 0.6-1.2 mg/dL. Normal BUN: 7-20 mg/dL. An increase of >0.3 mg/dL or 1.5x baseline in creatinine signals potential AKI.

Memory Tips

• Mnemonic for Cisplatin Toxicities: "Cisplatin Hurts Kidneys, Ears, Nerves" (C-H-K-E-N).
• Hydration is KEY: Think "Saline Saves Kidneys." For cisplatin, you flood the system with saline to protect the nephrons.

High-Frequency NCLEX Topics The NCLEX frequently tests priority interventions for specific drug toxicities. For cisplatin, hydration is almost always the correct answer when the question is about preventing kidney damage. Be ready to distinguish between monitoring for side effects (like checking CBC for myelosuppression) and actively preventing them (like hydration for nephrotoxicity).

Watch Out for Question Variations!

• Shift from "Prevent" to "Assess": "Which finding indicates the patient is experiencing cisplatin nephrotoxicity?" Answer: Rising serum creatinine, decreased urine output.
• Shift to Patient Education: "What should the nurse teach a patient receiving cisplatin?" Answer: "Drink plenty of fluids before and after treatment," and "Report any hearing changes or ringing in the ears."
• Priority Action with Multiple Problems: If a patient has low urine output AND a low platelet count, the priority is addressing the low urine output (risk for nephrotoxicity) over the low platelets (risk for bleeding), as kidney damage can be acute and irreversible.

Nursing Clinical Practice Guide Clinical Scenario: You are the oncology nurse preparing Ms. Johnson for her third cycle of cisplatin and paclitaxel for Stage III ovarian cancer. Her pre-treatment labs show Cr 0.9, BUN 18, Mg 1.8 mEq/L (low), and she mentions some mild tinnitus after her last treatment.

Nursing Intervention Strategy:

1. Pre-Infusion (Day Before/ Morning Of): Verify orders for pre-hydration (e.g., 1-2 liters of NS over 4-12 hours). Administer prescribed antiemetics (e.g., ondansetron, aprepitant) 30-60 minutes before chemo. Establish IV access, preferably with a central line (e.g., PICC) to avoid vesicant risk.
2. During Infusion: Hang the cisplatin bag, which is usually diluted in NS. Run it according to protocol (often over 1-6 hours). Continue concurrent hydration with NS. Monitor I&O hourly; goal urine output is >100 mL/hr. Assess for signs of infusion reaction or fluid overload (crackles, shortness of breath).
3. Post-Infusion: Continue hydration with NS for several hours after cisplatin is complete to ensure clearance. Encourage oral fluids. Provide dietary counseling for nausea management. Reinforce the need to report decreased urine output, hearing changes, or severe tingling in hands/feet.

Patient Safety and Precautions:

• Contraindications/Cautions: Do not administer if serum creatinine is significantly elevated. Use with extreme caution in patients with pre-existing renal impairment or hearing loss.
• Key Monitoring: Strict I&O, daily weights, renal function (pre- and post-cycle), electrolytes (Mg, K, Ca), and audiometry baseline and periodic checks.
• Drug Interaction: Concurrent use of other nephrotoxic drugs (aminoglycosides, NSAIDs) should be avoided.

Nursing Procedure & Medication Flow Cisplatin Administration & Hydration Protocol (Example):

1. Obtain baseline weight, vital signs, renal function, CBC, electrolytes.
2. Start IV hydration: 1-2 L NS over 4-6 hours pre-chemo.
3. Administer antiemetic regimen 30 min before cisplatin.
4. Prepare cisplatin: Usually 50-100 mg/m² diluted in 1-2 L NS.
5. Infuse cisplatin over 1-6 hours (per protocol) WITH CONTINUED HYDRATION.
6. Post-chemo hydration: 1-2 L NS over 4-8 hours.
7. Monitor I&O for 24-48 hours post-infusion. Total fluid intake may be 3-5 liters.

A Word from Your Senior Nurse "Oncology nursing requires a sharp eye for detail and proactive thinking. With cisplatin, we don't wait for the creatinine to rise – we act beforehand to keep those kidneys safe. Remember, your diligent assessment of I&O and your commitment to that hydration protocol can be the difference between a patient completing their life-saving treatment or having to stop due to toxicity. In clinicals and on the NCLEX, always link the drug to its signature toxicity and the nurse's signature intervention. That's how you provide excellent care and pass your boards with confidence!"